DMPK Consulting for IND Filing
I wanted to take a quick moment to thank NovusLife for providing DMPK expertise in support of our upcoming IND. My superior and I have over 50 years of experience in pre-clinical studies and have successfully worked on dozens of INDs. We had received some perplexing comments and statements from the FDA relative to DMPK data. I knew that we were both incapable of putting together the studies required and strategizing through the questions- we both looked for a solution for 1 month but could not find anyone with large molecule experience. After speaking with Andrew Young he quickly ascertained the issue and had one of his consultants in my inbox within 4 hours. I applaud NovusLife for their ability to grasp the nature of our problem and providing us a needed solution swiftly.
- Executive Director of Toxicology, biopharmaceutical targeting RNAi therapeuticsContact Us Blog Services